(2026). Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program. Degenerative Neurological and Neuromuscular Disease.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program."
Degenerative Neurological and Neuromuscular Disease 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program."
Degenerative Neurological and Neuromuscular Disease, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.